Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00907855 · ClinicalTrials.gov registry record
Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests
A clinical trial of Ischemic Heart Disease, sponsored by NYU Langone Health.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT00907855 is a study of Ischemic Heart Disease that has completed, run by NYU Langone Health. The registered enrollment target is 200 participants, below the 252-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00907855, a study of Ischemic Heart Disease, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiac stress testing with functional nuclear imaging is an invaluable technique in the diagnostic and prognostic evaluation of patients with known or suspected ischemic heart disease. Selection of the appropriate type of nuclear stress test: exercise stress Myocardial Perfusion Imaging (MPI) versus pharmacologic stress MPI is crucial for not only diagnostic accuracy and prognostic evaluation, but also for sound clinical decisions and resource utilization. The Duke Activity Status Index (DASI) is a 12-item questionnaire that utilized self-reported physical work capacity to estimate peak metabolic equivalents (METs) and has been shown to be a valid measurement of functional capacity. The investigators hypothesized that the DASI may be the screening tool that evaluates functional capacity and guides selection of the optimal stress MPI study.
Conditions Studied
Study Locations (1)
New York
- Nuclear Cardiology/Stress Lab, NYU Cardiology Division - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00907855
The ClinicalTrials.gov registry entry for NCT00907855 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 252-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (21% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ischemic Heart Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00907855 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00907855 about?
NCT00907855 is a clinical study titled "Using Duke Activity Status Index (DASI) to Select Optimal Cardiac Stress Tests". Cardiac stress testing with functional nuclear imaging is an invaluable technique in the diagnostic and prognostic evaluation of patients with known or suspected ischemic heart disease. Selection of the appropriate type of nuclear stress test: exercise stress Myocardial Perfusion Imaging (MPI) versu...
What is the current status of trial NCT00907855?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2009-04.
What conditions does trial NCT00907855 study?
This clinical trial studies the following conditions: Ischemic Heart Disease.
Who is sponsoring clinical trial NCT00907855?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00907855 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
-
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy
RECRUITING · Phase 2
-
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
RECRUITING · NA
-
Development of CIRC Technologies
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.